The Corona Study of Middle Norway

Completed

• Conditions: SARS-CoV-2 Acute Respiratory Disease; SARS-CoV-2 Sepsis; SARS CoV 2 Infection

• Registration Number: NCT05638178
• Lead Sponsor: St. Olavs Hospital

Brief Summary

CUT COVID is a cohort study establised to collect information on patients hospitalized because or with infection by SARS-CoV-2. The cohort data includes clinical data and biological samples from multiple timepoints during hospitalization, as well as data from a followup consultation 3 months after discharge.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-01
• Primary Completion: 2021-12-31
• Study Completion: 2022-08-12
• Study First Submitted: 2022-11-17
• Status Verified: 2022-12
• Study First Submitted QC: 2022-12-01
• Last Update Submitted: 2022-12-01
• Study First Posted: 2022-12-06
• Last Update Posted: 2022-12-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 223

Inclusion Criteria

• Positive SARS CoV-2 infection

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Predictors of COVID-19 severity	1 year after inclusion.	Primary aim is to assess predictors of severe COVID disease in children and adults

Trial Locations

Locations (5)

St. Olavs Hospital; 🇳🇴 Trondheim, MN, Norway

Molde Hospital; 🇳🇴 Molde, MR, Norway

Ålesund Hospital; 🇳🇴 Ålesund, MR, Norway

Levanger Hospital; 🇳🇴 Levanger, NT, Norway

Namsos Hospital; 🇳🇴 Namsos, NT, Norway